Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome.

Bullous impetigo due to Staphylococcus aureus is one of the most common bacterial infections of man, and its generalized form, staphylococcal scalded skin syndrome (SSSS), is a frequent manifestation of staphylococcal epidemics in neonatal nurseries. Both diseases are mediated by exfoliative toxins (ETs), which show exquisite pathologic specificity in blistering only the superficial epidermis. We show that these toxins act as serine proteases with extremely focused molecular specificity to cleave mouse and human desmoglein 1 (Dsg1) once after glutamic acid residue 381 between extracellular domains 3 and 4. Mutation of the predicted catalytically active serine to alanine completely inhibits cleavage. The mutated ETs bind specifically to Dsg1 by immunofluorescence colocalization and by coimmunoprecipitation. Thus, ETs, through specific recognition and proteolytic cleavage of one structurally critical peptide bond in an adhesion molecule, cause its dysfunction and allow S. aureus to spread under the stratum corneum, the main barrier of the skin, explaining how, although they circulate through the entire body in SSSS, they cause pathology only in the superficial epidermis.

[1]  K. Acharya,et al.  Structural similarities and differences in staphylococcus aureus exfoliative toxins A and B as revealed by their crystal structures , 2008, Protein science : a publication of the Protein Society.

[2]  Y. Hanakawa,et al.  Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. , 2002, The Journal of investigative dermatology.

[3]  F. Gisou van der Goot,et al.  The bacterial toxin toolkit , 2001, Nature Reviews Molecular Cell Biology.

[4]  S. Ladhani Recent developments in staphylococcal scalded skin syndrome. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  Zhi Hong Wang,et al.  Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1 , 2000, Nature Medicine.

[6]  J. Uitto,et al.  Protection against pemphigus foliaceus by desmoglein 3 in neonates. , 2000, The New England journal of medicine.

[7]  D. Ohlendorf,et al.  Staphylococcal Exfoliative Toxins Cleave α- and β-Melanocyte-Stimulating Hormones , 2000, Infection and Immunity.

[8]  D. Ohlendorf,et al.  Mutational Analysis of the Superantigen Staphylococcal Exfoliative Toxin A (ETA)1 , 2000, The Journal of Immunology.

[9]  D. Ohlendorf,et al.  The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. , 1999, Biochemistry.

[10]  S. Ladhani,et al.  Clinical, Microbial, and Biochemical Aspects of the Exfoliative Toxins Causing Staphylococcal Scalded-Skin Syndrome , 1999, Clinical Microbiology Reviews.

[11]  O. Pertz,et al.  A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E‐cadherin homoassociation , 1999, The EMBO journal.

[12]  Zhi Hong Wang,et al.  Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. , 1999, The Journal of clinical investigation.

[13]  Wayne A. Hendrickson,et al.  Structure-Function Analysis of Cell Adhesion by Neural (N-) Cadherin , 1998, Neuron.

[14]  J. Cavarelli EPIDERMOLYTIC TOXIN A FROM STAPHYLOCOCCUS AUREUS , 1997 .

[15]  T. Nishikawa,et al.  Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. , 1997, Journal of immunology.

[16]  D. Ohlendorf,et al.  The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. , 1997, Biochemistry.

[17]  M. Ikura,et al.  Structural basis of calcium-induced E-cadherin rigidification and dimerization , 1996, Nature.

[18]  C. Gemmell Staphylococcal scalded skin syndrome. , 1995, Journal of medical microbiology.

[19]  C. Bailey,et al.  The epidermolytic (exfoliative) toxins of Staphylococcus aureus , 1995, Medical Microbiology and Immunology.

[20]  T. Nishikawa,et al.  Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. , 1995, The Journal of investigative dermatology.

[21]  M. Ikura,et al.  Solution structure of the epithelial cadherin domain responsible for selective cell adhesion , 1995, Science.

[22]  J. Engel,et al.  Conformational changes of the recombinant extracellular domain of E-cadherin upon calcium binding. , 1994, European journal of biochemistry.

[23]  B. Cribier,et al.  Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. , 1994, Journal of the American Academy of Dermatology.

[24]  L. Parish,et al.  Cutaneous bacterial infections. How to manage primary, secondary, and tertiary lesions. , 1992, Postgraduate medicine.

[25]  P. O’Toole,et al.  Nucleotide sequence of the epidermolytic toxin A gene of Staphylococcus aureus , 1987, Journal of bacteriology.

[26]  Lee,et al.  Sequence determination and comparison of the exfoliative toxin A and toxin B genes from Staphylococcus aureus , 1987, Journal of bacteriology.

[27]  M. S. Steinberg,et al.  A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. , 1986, Journal of immunology.

[28]  M. S. Steinberg,et al.  Human autoantibodies against a desmosomal core protein in pemphigus foliaceus , 1984, The Journal of experimental medicine.

[29]  J. Klein,et al.  Infectious Diseases of the Fetus and Newborn Infant , 1983 .

[30]  H. Yokosawa,et al.  Thioltrypsin. Chemical transformation of the active-site serine residue of Streptomyces griseus trypsin to a cysteine residue. , 1977, Journal of biochemistry.

[31]  P. Elias,et al.  The fate of Staphylococcal exfoliatin in newborn and adult mice * , 1976, The British journal of dermatology.

[32]  K. Wolff,et al.  Staphylococcal toxic epidermal necrolysis: pathogenesis and studies on the subcellular site of action of exfoliatin. , 1975, The Journal of investigative dermatology.

[33]  M. Melish,et al.  Site of action of exfoliative toxin in the staphylococcal scaled-skin syndrome. , 1972, Pediatrics.

[34]  M. D. Turner,et al.  The staphylococcal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin. , 1972, The Journal of infectious diseases.

[35]  M. Melish,et al.  Staphylococcal scalded skin syndrome: the expanded clinical syndrome. , 1971, The Journal of pediatrics.

[36]  Hal B. Jenson,et al.  Nelson Textbook of Pediatrics , 1965 .

[37]  T. B. Cooley,et al.  THE BACTERIAL TOXINS. , 1901 .